[1] |
Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao.
Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512.
|
[2] |
Yan Guangxuan, Wang Xueyu, Wang Yujin, Lan Tinglong, Nie Wenjuan.
Diagnostic value of using metagenomic second-generation sequencing on suspected osteoarticular tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 175-180.
|
[3] |
Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei.
Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60.
|
[4] |
Chen Shuangshuang, Tian Lili, Wang Nenhan, Yang Xinyu, Zhao Yanfeng, Li Chuanyou, Dai Xiaowei.
Analysis of in vitro antibacterial effects of 17 antibiotics against rapidly growing mycobacteria in the Beijing area
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1056-1062.
|
[5] |
Wang Biao, Liu Yuhong, Sun Yuxian, Zhang Lijie, Li Zhili, Shu Wei.
Investigation and analysis of laboratory diagnostic capabilities in tuberculosis-designated hospitals in China
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1089-1097.
|
[6] |
Xue Yi, Liang Qian, Qi Haoran, Liang Ruixia, Huang Hairong.
Reliability analysis of rifampicin-resistance detected by different diagnostics as a predictor for multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 892-896.
|
[7] |
Tan Shouyong.
Research progress on comprehensive treatment beyond antibiotic therapy for nontuberculous mycobacterium pulmonary disease
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 967-970.
|
[8] |
Jia Hongyan, Fan Jun, Sun Qi, Song Ruixue, Du Boping, Dong Jing, Wang Yingchao, Xing Aiying, Zhu Chuanzhi, Li Zihui, Pan Liping.
Comparison of QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold In-Tube assay in auxiliary diagnosis of osteoarticular tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 648-653.
|
[9] |
Wang Liyan, Zhou Hui, Wu Qian, Hao Xiaogang, Lu Bingxin, Chen Bin.
Evaluation of the implementation effect of the “Zero Burden” strategy for diagnosis and treatment of pulmonary tuberculosis in Longyou County, Zhejiang Province
[J]. Chinese Journal of Antituberculosis, 2024, 46(4): 418-423.
|
[10] |
Li Ting, Liu Shuang, Wang Danxia, Lu Jia, Cheng Qianqian, Chen Chuang, He Jin’ge, Zhang Linglin, Xia Yong, Li Jing, Zhang Shu, Gao Wenfeng, Xia Lan.
Evaluation of health economics of implementation of tuberculosis prevention and control program in Sichuan Province from 2011 to 2020
[J]. Chinese Journal of Antituberculosis, 2024, 46(3): 333-339.
|
[11] |
Li Xuelian, Jing Wei, Wang Qingfeng, Chu Naihui, Nie Wenjuan.
An all-oral shortened regimen containing new drugs to treat MDR/rifampicin-resistant tuberculosis: three case reports and literature review
[J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1327-1334.
|
[12] |
Hu Qiang, Jin Linyuan, Zhou Xiaohui, Zhang Qianrong, Deng Yuhang, Tang Xianpeng, Zhou Haiyi, Zhang Min.
The value of ultrasound examination in the diagnosis and treatment evaluation of chest tuberculosis in children
[J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1350-1355.
|
[13] |
Song Hongge, Liu Weigao.
Evaluation of the curative effect of total hip joint type space holder in the treatment of middle and advanced hip joint tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(8): 781-785.
|
[14] |
Yue Yongning, Fan Dapeng, Shang Xuechai, Li Hao, Li Huanyu, Zhou Jinyang, Cai Long.
Evaluation of the effect of BS-400 Automatic Mycobacterium Liquid Culture System on Mycobacterium culture
[J]. Chinese Journal of Antituberculosis, 2023, 45(5): 483-487.
|
[15] |
Mao Hongkai, Zhang Yan, Liang Zhichao, Xia Wenjun, Bao Liangliang, Mayisha·Daken , Wang Xiaomin, Cao Mingqin.
Evaluation of implementation effect of pulmonary tuberculosis prevention and control strategy in southern Xinjiang based on synthetic control method
[J]. Chinese Journal of Antituberculosis, 2023, 45(4): 383-390.
|